Reshetnyak, T. M.
Cheldieva, F. A.
Glukhova, S. I.
Nurbaeva, K. S.
Seredavkina, N. V.
Cherkasova, M. V.
Lila, A. M.
Nasonov, E. L.
Article History
Received: 3 February 2025
Revised: 9 February 2025
Accepted: 9 February 2025
First Online: 11 May 2025
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
: The study was approved by the local ethics committee (protocol no. 25 of December 23, 2021). All patients were observed at the Nasonova Research Institute of Rheumatology and underwent standard clinical, laboratory, and instrumental examination recommended by the Association of Rheumatologists of Russia. All patients signed informed consent to participate in the study. Laboratory examination included a general clinical blood test, biochemical blood test, and general urine test.
: The authors of this work declare that they have no conflicts of interest. The authors bear full responsibility for submitting the final version of the manuscript for publication.